Quantumzyme Corp. 8-K

What Happened

• Quantumzyme Corp. (filed 8-K on Feb 13, 2026) announced that its Board approved an amendment to the Articles of Incorporation to change the company name to Quantum Genesis AI Corp. The Board approval occurred Jan 7, 2026 and a stockholder holding 79.56% of voting power approved the change by written consent on Nov 30, 2025.
• The Company filed a Certificate of Amendment with the Nevada Secretary of State on Feb 11, 2026, and the name change became effective upon filing. FINRA processed the name and OTC symbol changes on Feb 13, 2026; the new trading symbol "QGAI" will take effect at market open on Feb 17, 2026.

Key Details

• Board approval date: January 7, 2026; stockholder written consent: November 30, 2025.
• Certificate of Amendment filed and effective: February 11, 2026.
• FINRA announcement: February 13, 2026; market effective date for new symbol QGAI: February 17, 2026.
• No change to shareholder rights, authorized capital, issued and outstanding shares, par value, or CUSIP number.

Why It Matters

• For investors, the primary practical impact is the company’s new public name and ticker: Quantum Genesis AI Corp., ticker QGAI (effective Feb 17, 2026). Update watchlists and trading instructions to avoid confusion.
• There is no change to the company’s capital structure or shareholders’ holdings—ownership percentages and share counts remain the same, and the CUSIP is unchanged—so this is an administrative change, not a corporate reorganization or dilution.